Financials
- Market Capitalization 5.81 B
- Employee 370
- Founded 1996
- CEO N/A
- Website www.xenon-pharma.com
- Headquarter British Columbia, Canada
- FIGI BBG0073DM784
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-12.73
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1232 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 105.84 USD | -5.11% | -3.85% | +0.19% | +352.50% | 5.92 B USD | ||
| 1240 | PTCT PTC Therapeutics, Inc. - Common Stock | 70.09 USD | -2.40% | +0.60% | +4.33% | +41.68% | 5.85 B USD | ||
| 1276 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 280.49 USD | -1.42% | -2.02% | -2.32% | +49.90% | 5.59 B USD | ||
| 1279 | CRSP CRISPR Therapeutics AG - Common Shares | 57.72 USD | -2.78% | -1.52% | +20.15% | +13.18% | 5.58 B USD |